Deferred Tax Assets, Valuation Allowance of China SXT Pharmaceuticals, Inc. from 31 Mar 2022 to 31 Mar 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: China SXT Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Mar 2022 to 31 Mar 2025.
China SXT Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Mar 2025 was $1,441,907, a 15% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

China SXT Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2025	$1,441,907	+$191,802	+15%	31 Mar 2025	20-F	31 Jul 2025	2025	FY
Q3 2024	$1,283,601	+$321,449	+33%	30 Sep 2024	6-K	28 Mar 2025	2025	Q2
Q1 2024	$1,250,105	+$373,301	+43%	31 Mar 2024	20-F	31 Jul 2025	2025	FY
Q3 2023	$962,152			30 Sep 2023	6-K	05 Apr 2024	2024	Q2
Q1 2023	$876,804	+$344,436	+65%	31 Mar 2023	20-F	13 Aug 2024	2024	FY
Q1 2022	$532,368			31 Mar 2022	20-F	31 Jul 2023	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.